HTT and Huntington disease: Targeting the genetic cause of HD by lowering the product of huntingtin gene (HTT) or specifically the harmful HTT is still promising but preclinical findings are still essential to open new windows to treat HD by focusing on the cellular consequences of mutant HTT (mHTT) expression.